 |
|
Molecular Therapy for Spinal Muscular Atrophy Closer to Clinical Use
December 17, 2008COLUMBIA, Mo. - Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births. While trans-splicing (a form of molecular therapy) has had impressive results as a treatment for spinal muscular atrophy in cell-based models of disease, scientists have been unable to translate the therapy to the human body. A University of Missouri researcher has developed a strategy that will enhance trans-splicing activity and bring it closer to being used in the clinical setting.
Spinal muscular atrophy is caused by the loss of survival motor neuron-1(SMN1). In humans, a nearly identical copy gene is present called SMN2. Because of a single molecular difference, SMN2 alone cannot compensate for the loss of SMN1, but it can be used as a primary target for therapeutics, including trans-splicing. Trans-splicing therapy relies on splicing, or uniting, of mutant RNA and therapeutic RNA in order to correct RNA sequence.
To improve efficiency, the researchers developed a trans-splicing system that uses a strand of RNA that can bind to a gene and inactivate it. Turning the gene "off" reduces competition at splice sites and improves the likelihood of achieving the desired results.
"The key to introducing trans-splicing in clinical settings is developing efficient trans-splicing systems," said Chris Lorson, investigator in the Christopher S. Bond Life Sciences Center; associate professor of veterinary pathobiology in the MU College Veterinary Medicine; and scientific director for Fight SMA, a private spinal muscular atrophy research foundation in Richmond, Va. "We have found that reducing the competition between the splice sites enhances the efficiency of trans-splicing. This strategy provides insight into the trans-splicing mechanism and significantly improves trans-splicing activity in a mouse model of spinal muscular atrophy."
The study, "Development of a Single Vector System that Enchances Trans-splicing of SMN2 Transcripts," was published in PLoS ONE and was co-authored by Lorson; MU researchers Tristan H. Coady, Travis D. Baughan and Monir Shababi; and Genzyme Corporation neuroscience researcher Marco A. Passini.
University of Missouri
"The key to introducing trans-splicing in clinical settings is developing efficient trans-splicing systems," said Chris Lorson, investigator in the Christopher S. Bond Life Sciences Center; associate professor of veterinary pathobiology in the MU College Veterinary Medicine; and scientific director for Fight SMA, a private spinal muscular atrophy research foundation in Richmond, Va. "We have found that reducing the competition between the splice sites enhances the efficiency of trans-splicing. This strategy provides insight into the trans-splicing mechanism and significantly improves trans-splicing activity in a mouse model of spinal muscular atrophy."
The study, "Development of a Single Vector System that Enchances Trans-splicing of SMN2 Transcripts," was published in PLoS ONE and was co-authored by Lorson; MU researchers Tristan H. Coady, Travis D. Baughan and Monir Shababi; and Genzyme Corporation neuroscience researcher Marco A. Passini.
University of Missouri
Spinal Muscular Atrophy Current Events and Spinal Muscular Atrophy News RSSResearchers identify drug candidate for treating spinal muscular atrophy
A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants.
ISU researchers find possible treatment for Spinal Muscular Atrophy
Spinal Muscular Atrophy is the second-leading cause of infant mortality in the world.
UCLA stem cells scientists make electrically active motor neurons from iPS cells
Stem cells scientists at UCLA showed for the first time that human induced pluripotent stem (iPS) cells can be differentiated into electrically active motor neurons, a discovery that may aid in studying and treating neurological disorders.
MU logo News Bureau University of Missouri About the News Bureau Contact Us Home / News Releases / 2009 MU Researchers Discover Target that Could Ease Spinal Muscular Atrophy Symptoms
There is no cure for spinal muscular atrophy (SMA), a genetic disorder that causes the weakening of muscles and is the leading genetic cause of infant death, but University of Missouri researchers have discovered a new therapeutic target that improves deteriorating skeletal muscle tissue caused by SMA. The new therapy enhanced muscle strength, improved gross motor skills and increased the lifespan in a SMA model.
Patient-derived induced stem cells retain disease traits
hen neurons started dying in Clive Svendsen's lab dishes, he couldn't have been more pleased. The dying cells - the same type lost in patients with the devastating neurological disease spinal muscular atrophy - confirmed that the University of Wisconsin-Madison stem cell biologist had recreated the hallmarks of a genetic disorder in the lab, using stem cells derived from a patient.
Genetic test for spinal muscular atrophy should be offered to all couples, says the ACMG
Carrier screening for spinal muscular atrophy (SMA)-a serious genetic disease affecting approximately 1 in 10,000 infants that causes progressive muscle weakness and death-should be made available to all families, according to a new practice guideline issued by the American College of Medical Genetics (ACMG).
Penn researchers gain new insights on spinal muscular atrophy
Researchers from the University of Pennsylvania School of Medicine discovered that the effect of a protein deficiency, which is the basis of the neuromuscular disease spinal muscular atrophy (SMA), is not restricted to motor nerve cells, suggesting that SMA is a more general disorder.
Cold Spring Harbor Laboratory Scientists Devise Potential Approach To Treat Spinal Muscular Atrophy
In the neuromuscular disease called spinal muscular atrophy, or SMA, a protein deficiency caused by a single gene mutation leads to serious damage in growing nerve cells and the muscles they control.
CSHL shows correcting rna splicing may help treat spinal muscular atrophy
RNA splicing antisense technology studied at Cold Spring Harbor Laboratory (CSHL) effectively corrected an mRNA splicing defect found in spinal muscular atrophy (SMA) patients, and is now ready to be tested in mouse models.
Treatment extends survival in mouse model of spinal muscular atrophy
Drug therapy can extend survival and improve movement in a mouse model of spinal muscular atrophy (SMA), new research shows. The study, carried out at the NIH's National Institute of Neurological Disorders and Stroke (NINDS), suggests that similar drugs might one day be useful for treating human SMA.
More Spinal Muscular Atrophy Current Events and Spinal Muscular Atrophy News Articles
 |
Living with Spinal Muscular Atrophy: The True Story of Kassidy Jade Sears by Trina Allen (Author) Kassidy was born into the world just months prior to the soon to be roller-coaster ride her young parents would face. Kassidy was the only child and the only grandchild at this time, which seemed healthy and happy. Such devastating news would soon follow the day she turned three months old. The strength and courage that Kassidy had will never be forgotten. The love that this little girl had for her mommy and the love that her mommy had for her will always be remembered. The question we all asked "Why God? Why us? Why our Kassidy?" a question that we still ask today and will for years to come. |
 |
ABC News UpClose Spinal Muscular Atrophy Parents, who are running in a race against time to save their daughter's life, are told that the best thing they could do is to find someone famous who has the disease or, in the very least, is willing to be a spokesperson for it. Arya Singh has an awful disease called Spinal Muscular Atrophy, or SMA. Although most people have never heard of this disease, it's nearly as prevalent as Lou Gehrig's Disease or Cystic Fibrosis. But unlike many lethal diseases, scientists know what causes SMA and have a good idea of how to treat, if not cure it. With just a few more years and a lot more money, it may be a manageable illness. But right now, the money isn't there. And Arya Singh's and thousands of lives, mostly children's, hang in the... |
 |
Spinal Muscular Atrophy Awareness Ribbon Mouse Pad by MyHeritageWear.com The Spinal Muscular Atrophy Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Spinal Muscular Atrophy Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Spinal Muscular Atrophy Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
 |
Spinal Muscular Atrophy Medical Guide by Qontro Medical Guides (Author) The Spinal Muscular Atrophy Medical Guide is a publication which has been designed to better help readers understand Spinal Muscular Atrophy. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Spinal Muscular Atrophy. The Spinal Muscular Atrophy Medical Guide is highly recommended for those interested in understanding and learning more about Spinal Muscular Atrophy. |
 |
Spinal Muscular Atrophy - A Bibliography and Dictionary for Physicians, Patients, and Genome Researchers by Philip M. Parker (Author) In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing. Since only the smallest fraction of information dealing with spinal muscular atrophy is indexed in search engines, such as www.google.com or others, a non-systematic approach to Internet research can be not only time consuming, but also incomplete. This book was created for medical professionals, students, and members of the general public who want to conduct medical research using the most... |
 |
The Official Parent's Sourcebook on Spinal Muscular Atrophy: A Revised and Updated Directory for the Internet Age by Icon Health Publications (Author) This book has been created for parents who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells parents where and how to look for information covering virtually all topics related to spinal muscular atrophy (also Infantile Spinal Muscular Atrophy, Type I; Juvenile Spinal Muscular Atrophy Type III; SMA, Infantile Acute Form; Spinal Muscular Atrophy Type I; Spinal Muscular Atrophy Type III; Werdnig-Hoffman Paralysis), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected... |
 |
The Me in the Mirror by Connie Panzarino (Author) Born with a rare muscle disease, the author recounts the challenges of growing up handicapped, her early adulthood and dawning political activism, her relationship with Vietnam veteran Ron Kovic, her lesbianism, and her work as a disability rights activist. Original. |
|
Spinal muscular atrophy: An entry from Thomson Gale's Gale Encyclopedia of Neurological Disorders by Borut, MD, PhD Peterlin (Author) Targeted to patients, their families and allied health students, The “Gale Encyclopedia of Neurological Disorders” provides in-depth coverage of neurological diseases and disorders, including stroke, multiple sclerosis, Parkinson disease, Tourette Syndrome, Alzheimer's disease, cerebral palsy, vertigo, amnesia and epilepsy. Related topics include communication aids, electric personal assistive mobility devices, medications for treating neurological diseases and conditions, understanding the needs of Alzheimer patient caregivers and more. This two-volume set provides an alternative to resources that either fail to explore neurological disease in any depth and or do so at a level not appropriate for students and general readers. | |
|
Progressive Spinal Muscular Atrophies (The International Review of Child Neurology) by Ingrid Gamstorp (Author) | |
|
Nutrition issues associated with spinal muscular atrophy. (Review).: An article from: Nutrition & Dietetics: The Journal of the Dieticians Association of Australia by Sarah Leighton (Author) This digital document is an article from Nutrition & Dietetics: The Journal of the Dieticians Association of Australia, published by Thomson Gale on June 1, 2003. The length of the article is 4286 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Nutrition issues associated with spinal muscular atrophy. (Review). Author: Sarah Leighton Publication: Nutrition & Dietetics: The Journal of the Dieticians Association of Australia (Magazine/Journal) Date: June 1, 2003 Publisher: Thomson Gale Volume: 60 Issue: 2 Page: 92(5) Distributed by Thomson... |
| © 2009 BrightSurf.com |